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Abstract
Purpose This randomized clinical equivalence trial was
designed to evaluate health-related quality of life (HRQoL)
after fast-track treatment for low-risk coronary artery
bypass (CABG) patients.
Methods Four hundred and ten CABG patients were
randomly assigned to undergo either short-stay intensive
care treatment (SSIC, 8 h of intensive care stay) or control
treatment (care as usual, overnight intensive care stay).
HRQoL was measured at baseline and 1 month, and one
year after surgery using the multidimensional index of life
quality (MILQ), the EQ-5D, the Beck Depression Inven-
tory and the State-Trait Anxiety Inventory.
Results At one month after surgery, no statistically sig-
niﬁcant difference in overall HRQoL was found (MILQ-
score P-value = .508, overall MILQ-index P-value =
.543, EQ-5D VAS P-value = .593). The scores on the
MILQ-domains, physical, and social functioning were
signiﬁcantly higher at one month postoperatively in the
SSIC group compared to the control group (P-value =
.049; 95%CI: 0.01–2.50 and P-value = .014, 95% CI:
0.24–2.06, respectively). However, these differences were
no longer observed at long-term follow-up.
Conclusions According to our deﬁnition of clinical
equivalence, the HRQoL of SSIC patients is similar to
patients receiving care as usual. Since safety and the
ﬁnancial beneﬁts of this intervention were demonstrated in
a previously reported analysis, SSIC can be considered as
an adequate fast-track intensive care treatment option for
low-risk CABG patients.
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Abbreviations
BDI Beck depression inventory
CABG Coronary artery bypass grafting
IC Intensive care
MILQ Multidimensional index of life quality
HRQoL Health-related quality of life
SSIC Short-stay intensive care
STAI-S State anxiety scale
95% CI 95% conﬁdence interval
Introduction
Rapid technological advancements changed the practice of
intensive care medicine in the last few decades. These
improvements facilitated the introduction of fast-track
protocols for the treatment of cardiac surgical patients,
which are very popular as they contribute to a more efﬁ-
cient utilization of the existing care facilities. Various
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on the evaluation of the clinical effectiveness of different
types of fast-track treatments [1–3].
However, for the evaluation of these intensive care
interventions it is essential to assess its impact on health-
related quality of life [4]. These patient-reported outcomes
contain valuable information for intensive care physicians,
other healthcare providers, policymakers, patients, and
their relatives.
Several fast-track trials incorporated HRQoL as an
outcome measure in their evaluations, but only one
speciﬁc domain with a short follow-up time has been
assessed [5–17]. These limited assessments are helpful in
describing the domains of patient outcome in a speciﬁc
area of HRQoL. However, they are not designed to
evaluate either the overall health state [18] or all
domains of QoL that may contain important aspects of
health. For a comprehensive evaluation of HRQoL, it is
important to assess both overall or generic HRQoL and
disease-speciﬁc HRQoL [19]. We chose to use the
EQ-5D, as a generic measure, because it is brief, simple,
and easy to administer. The reliability and validity for
the EQ-5D has been studied in cardiac patients [20, 21]
and in critical care patients [22]. In a previous paper, we
also reported generic HRQoL at 1 month after surgery as
an outcome measure in the economic evaluation of the
short-stay intensive care treatment [23]. The patient’s
answers to the ﬁve EQ-5D items were used to calculate
the utility value (a score of 0–1), based on population
weights [24]. In the current study, this outcome was not
reported because the aim of this previous paper was to
report data from a patient’s point of view and not from a
societal perspective. As a disease-speciﬁc measure, the
multidimensional index of life quality (MILQ) was
chosen. Although this questionnaire is not frequently
used, its reliability and validity has been tested by Avis
et al. [25] for cardio vascular patients. In addition, we
were interested in assessing the impact of the fast-track
treatment on anxiety and depression, as these psycho-
logical aspects of HRQoL may be affected after cardiac
surgery [26].
As several studies [22, 27–29] on intensive care
admission have demonstrated the importance of long-term
follow-up, in addition to 1-month follow-up, we assessed
the impact of the fast-track treatment on HRQoL at 1 year
after surgery.
The focus of this randomized clinical equivalence
trial is to evaluate the impact of a fast –track protocol,
i.e., early discharge -within 8-h of postsurgical coronary
artery bypass patients from intensive care to medium care
(MC) on disease-speciﬁc, generic, and domain-speciﬁc
(anxious and depressive feelings) HRQoL up to 1 year
postoperatively.
Materials and methods
Study design and hypothesis
This single blinded randomized clinical equivalence trial
was designed to evaluate the HRQoL of low-risk CABG
patients at 1 year postoperatively who were randomized for
either short-stay intensive care (SSIC\8 h) or overnight
intensive care stay (control group patients). The choice of
the study design was based on the expected therapeutic
equivalence of the SSIC treatment and the care as usual.
We assumed there would be fewer costs in the SSIC group
but comparable clinical effectiveness and QoL outcomes in
both trial arms. The clinical- and cost-effectiveness out-
comes of the SSIC trial are reported elsewhere [23].
The following hypothesis was formulated to evaluate the
primary outcome:
At one-year postoperatively, the disease-speciﬁc HRQoL
(measured by means of MILQ) will be similar in both
groups.
Two additional hypotheses were formulated to assess the
secondary outcome measures:
At one year after surgery, both generic HRQoL (mea-
sured by means of EQ-5D) and domain-speciﬁc HRQoL
(measured by means of Beck Depression Inventory and
Spielberger State Anxiety Scale) will be similar in both
groups.
At one month postoperatively, disease-speciﬁc, generic,
and domain-speciﬁc HRQoL will also be similar for both
groups.
Patients
All CABG patients who were admitted to the University
Hospital of Maastricht in the period between February 2001
and March 2003 were considered for inclusion. High-risk
CABG patients were separated from the low-risk patients by
means of a risk stratiﬁcation system, based on the criteria of
Parsonnet score [30] and the Society of Thoracic Surgeons
[31].Theexclusioncriteriaweredeﬁnedasfollows:ageolder
than 78, ejection fraction of less than 30%, stage 3 obesity
(BMI[40 kg/m
2), hemodialysis (kidney-replacing therapy),
pulmonary hypertension (systolic pressure\40 mmHg),
recent cardiovascular accident (\1 month), recent myocar-
dial infarction (\24 h), cardiogenic shock (systolic
blood pressure\80 mmHg, -central ﬁlling pressure of
[20 mmHg, -cardiac index of\1.8 Lmin
-1m
-2), or the
need for inotropic therapy ([5 mg/lg
-1min
-1/dopamine or
dobutamine), ongoing infarction (a signiﬁcant increase in
myocardial muscle creatine kinase isoenzyme MB within
4 h before surgery), or the need for intra-aortic balloon
pump. Other reasons for exclusion were, for instance,
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123inability to give informed consent, inability to speak/read/
understand the Dutch language and emergency surgery. The
local ethical and research council approved the study.
Randomization and blinding
Beforestartingthestudy,alistofrandomlypermutatedblocks
(with a length of 10) were generated for either ‘‘control’’
(n = 300) or ‘‘SSIC’’ (n = 300) by a computer, and the
results were entered sequentially into numbered, opaque
envelopes,sealedwithtape.TheenvelopeswereopenedbyIC
nurses immediately upon IC admission. Patients and the sur-
gical team were blinded to the group assignments.
Treatment
Until IC admission, treatment was similar for both groups.
In the IC, both groups received standard IC monitoring. In
order to allow the transfer of SSIC patients from IC to MC
within 8 h, the discharge criteria described in Table 1 had
to be fulﬁlled. The ﬂow chart (Fig. 1) shows the timelines
for both groups. The SSIC patients who did not fulﬁll the
discharge criteria within 8 h and all control group patients
were treated according to usual care.
For logistical reasons, it was not possible to transfer
SSIC patients who fulﬁlled the criteria for discharge within
8 h from the IC to the MC situated on another ﬂoor in the
hospital. Consequently, the nurse/patient ratio of one nurse
to one patient was maintained. However, the care provided
by the nurse was adapted to the MC guidelines. In the
morning after surgery, all patients were transferred to a MC
ward connected to the general ward. The nurse/patient ratio
in this MC was one nurse to two patients. Patients stayed
there for another 24 h.
On the second postoperative day, patients were admitted
to the general ward, where they stayed until discharge or
transfer to the district hospital.
Procedures HRQoL measurement
After obtaining informed consent, HRQoL questionnaires
were self-administered by the patients the day before surgery
at the hospital, at 1-month and one-year postoperatively at
home. If a patient was unable to complete the questionnaire
individually, the research nurse performed an interviewed
administration. The application of the four HRQoL instru-
ments took almost 20 min and was done in a ﬁxed order, ﬁrst
the EQ-5D, secondly the MILQ, followed by Spielberger
State-Trait Anxiety Inventory (STAI-S) and Beck Depres-
sion Inventory (BDI). Patients who did not respond to the
follow-up questionnaires received a written reminder. If the
patients still did not respond, they were contacted by tele-
phone to ﬁnd out the reasons for non-response.
HRQoL questionnaires
Themultidimensionalindexoflifequality(MILQ),aHRQoL
measure specially developed for cardiovascular disease, was
used to measure disease-speciﬁc QoL [25]. In the ﬁrst item
(whichisreferredtoasthe ‘‘MILQ-score’’), the respondentis
asked to rate his/her general HRQoL on a seven-point scale
(from 1 = worst to 7 = best possible HRQoL score). In the
other 35 items, the respondent’s degree of satisfaction with
various aspects of quality of life is scored on a seven-point
scale(from1 = verydissatisﬁedto1 = verysatisﬁed).These
items cover the following nine domains: mental health,
physical health, physical functioning, cognitive functioning,
socialfunctioning,intimacy,ﬁnancialstatus,relationshipwith
health professionals, and productivity. As each domain con-
tainsfouritems,thetotaldomainscorecanrangefrom4to28
(except for the domain of productivity which contains three
items, the total score range from 3 to 21). The Dutch trans-
lation of the MILQ has been used to assess the HRQoL of
CABG–patients[32].Anunweightedindexwascalculatedby
adding up over all nine-domain scores, will possible scores
Table 1 Description of criteria for discharge from IC for both control
and short-stay intensive care (SSIC) patients
Pulmonary
Patient needs to be extubated for at least 30 min before he/she can
be transferred to the MC
a
Breathing frequency C 10 B 25 times per minute
Arterial blood gas pO2[10 kPa
b and the PCO2
c \6.0 Kpa,
depending on clinical glance can be deviated form this value
(in consultation with ward doctor)
Cardiac
Patient has no ongoing infarction (a signiﬁcant increase in enzyme
‘‘CKMB’’
d) or ischemic changes on the ECG
e or arrhythmia with
hemodynamic consequences
Fluid balance
Patient has B 100 ml chest tube drainage per hour and a
diuresis[0.5 ml/kg/hour
Neurological
Patient has no signs/symptoms of neurological complications
Hemodynamic and supporting therapy
Patient does not need inotropic support or sodium nitroprusside
(NTG
f and dopamine (2 mcg/kg/min) are allowed)
Patient does not have an intra-aortic balloon pump
Patient with pulmonary artery catheter: the last measured cardiac
index C 2 L/min/m
2 or mixed venous saturation (55–60%)
a MC Medium Care
b Kpa Kilo Pascal
c PCO2 Partial Pressure of Carbon Dioxide
d CKMB Creatine Kinase Mb
e ECG Electrocardiogram
f NTG Nitroglycerine
Qual Life Res (2010) 19:631–642 633
123range from 35 to 245 (which is referred to as the ‘‘overall
MILQ-index’’).
Furthermore, generic HRQoL was measured by the EQ-
5D [33]. The EQ-5D consists of two components: an EQ-5D
descriptive system and an EQ-5D Visual Analogue Scale
(EQ-5D VAS). In the descriptive system, the respondent is
asked to rate his or her health by checking one of three
levels of severity—‘‘no problems’’ (coded as 1), ‘‘some or
moderate problems’’ (coded as 2), ‘‘severe problems or
unable to perform’’ (coded as 3)- in each of the following 5
EQ-5D dimensions: mobility, self-care and pain/discomfort,
usual activities, and anxiety/depression. For the EQ-VAS,
participants draw a line from a box to the point on the
thermometer-like scale corresponding to their health state
(with a range from 0 ‘‘the worst imaginable health state’’ to
100 ‘‘the best imaginable health state’’). Depression was
evaluated by means of BDI [34]. The STAI-S was used to
measure temporal and transient aspects of anxiety [35].
Both STAI-S (20 items) and BDI (21 items) contain items
expressed as four-point scales. Both BDI and STAI have
been used in studies with CABG patients [36–38] and are
considered to be validated and reliable instruments [34, 35].
One-year quality of life equivalence and power analysis
Equivalence in health-related HRQoL was deﬁned a priori.
It was expected that the disease-speciﬁc HRQoL (MILQ)
would measure the most sensitive to detect differences
between the groups. The overall MILQ-index varies
between 1 (worst of health) and 7 (best of health). Equiv-
alence on the overall MILQ-index at 1 year was assumed if
the SSIC and the control group would not differ within a
tolerance range of 5%, i.e., within 0.4 on a seven-point
scale. It was assumed that the standard deviation of this
difference would be 1.15 [32]. Based on this, so with a two-
sided test, alpha of 0.05, a power of 90%, and an expected
drop-out percentage of 10%, the number of patients needed
amounted to 194 for each study group. For the EQ-5D
domains and EQ-5D VAS, the power calculations deter-
mined a difference of 0.3 points on the EQ-5D domains and
a difference of 8 points on the EQ-5D VAS could be
detected with 90% power.
Statistical analysis
The reasons for non-response were categorized as follows:
‘‘Informative censoring’’ (if reason was non-random e.g.,
related to the health status) [39], ‘‘non-informative cen-
soring’’ (if reason was random) [39], and ‘‘unclear’’ (if
reason was unknown).
All analyses were conducted following the intention-to-
treat principle. Missing values were imputed by the sepa-
rate mean group scores of non-missing patients for the
SSIC and the control groups. We performed the analysis
with and without mean imputation, and we did not ﬁnd a
difference in study ﬁndings.
1062 patients were admitted to the University Hospital for CABG 
surgery in the period from March 2001 until February 2003
702 patients fulfilled the inclusion criteria
600 informed consent
360 patients were excluded
102 refused
First 410 QoL-study
Allocated to control group (N=208)
-Exclusion  (n=1)
1 patient appeared to have < 30% left ventricle
ejection fraction intra operatively
Allocated to SSIC group (N=202)
-Exclusion  (n=1)
1 patient died during surgery 
190 excluded from QoL-study
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Available for analysis (N=206)
Available for analysis (N=181)
Available for analysis (N=194)             
Missing QoL questionnaires* (n=1)
Missing QoL questionnaires* (n=13)
Missing QoL questionnaires* (n=26)
Baseline
One month after surgery
One year after surgery
Available for analysis (N=200)
Available for analysis (N=180)
Available for analysis (N=191)             
Missing QoL questionnaires* (n=1)
Missing QoL questionnaires* (n=10)
Missing QoL questionnaires* (n=21)
Fig. 1 Flow chart of patient inclusion ( for reasons see Table 3)
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standard deviations and at follow-up as mean change
scores (baseline minus 1 month or 1 year minus 1 month)
with a 95% conﬁdence interval (95% CI) for both groups.
The Kolmogorov–Smirnov test was used to test for nor-
mality of differences between postoperative and preoper-
ative scores. Student t-tests were performed to examine the
mean differences in HRQoL change between both treat-
ment groups at 1 month after surgery.
Repeated measures ANCOVA using the preoperative
scores as a covariate was performed to test equivalence of
HRQoL scores at 1 year. Interaction effects between pre-
operative HRQoL and the treatment modality group on
one-year differences in HRQoL were also tested for sta-
tistical signiﬁcance. Next, in regression analyses with the
MILQ-score, the overall MILQ-index or the EQ-5D VAS
as dependent variables the relationships with other factors
were tested. Selection of the potential predictors in the
regression models was based on results of previous
research (see appendix). Regression modeling was done
with list wise deletion of missing cases using both forward
selection and backward elimination techniques. Predictors
statistically signiﬁcant in both techniques were selected in
the model, except for treatment modality group, which was
always kept within the model, irrespective of its statistical
signiﬁcance. Final regression model results are presented in
a table with unstandardized effects, P-values and variance
explained (R-square) by each ﬁnal model.
A P-Value of less than 0.05 was assumed to be statis-
tically signiﬁcant. All analysis was performed using SPSS-
pc version 12.0.1 (SPSS, Chicago, IL).
Results
Study population
Between February 2001 and March 2003, 702 out of the
1062 available CABG patients were eligible for inclusion
in the clinical part of the study (Fig. 1). They were asked to
give informed consent. A total of 600 patients gave
informed consent and participated in the SSIC trial. For
this QoL-study, only the ﬁrst 410 of the included CABG
patients were needed.
The study population consisted of a group of low-risk
CABG patients with a mean age of 62 years, and 80% of
them were men (Table 2).
The non-response rates were low and appear to be
similar for control and SSIC groups in all three categories
(informative, non-informative, and unclear) and at the three
measurement times (Table 3). Four patients died (control
n = 1 and SSIC n = 3) and one patient was readmitted to
hospital. These events were unrelated to the IC treatment
received. After ruling out mortality, 39 follow-up ques-
tionnaires (4.8% of the total) were not sent back for reasons
that were unclear.
The non-responders were mainly women with no
partner who had slightly longer surgery times and hospital
stays compared to the responders. However, there was no
difference in patient characteristics between the non-
responders in the control group and the non-responders in
the SSIC group (data not shown).
Baseline HRQoL outcomes appeared not to be signiﬁ-
cantly different between SSIC and control group (P-Values
not shown).
Disease-speciﬁc health-related quality of life
At 1 month after surgery, the change scores (1 month
postoperative minus baseline) of both the MILQ-score and
overall MILQ-index were not signiﬁcantly different between
the two treatment groups (MILQ-score P-Value = .270;
95% CI: -0.11–0.40, overall MILQ-index P-Value = .154,
95% CI: -1.49 to -9.41) (Table 4). However, the domains’
physical and social functioning of the MILQ were signiﬁ-
cantly better in the SSIC group compared to the control
group (respectively, P-Value = .049, 95%CI: 0.01–2.50 and
P-Value = .014, 95% CI: 0.24–2.06) (Table 4).
Results of the repeated measures ANCOVA analysis
with the baseline QoL scores as covariates show no sta-
tistically signiﬁcant differences between the SSIC group
and the control group in the linear trend in the year after
surgery on the MILQ-score (P-Value = .508), nor on the
overall MILQ-index (P-Value = .543) (Table 4).
In the regression models, the linear trend of the MILQ-
score and the linear trend of the overall MILQ-index were
used as dependent variables. Controlled for potential con-
founding factors, the type of intensive care treatment
received was again not a signiﬁcant predictor of HRQoL
(MILQ-score P-Value = .736, 95% CI: -.115–.162, nor
for the overall MILQ-index P-Value = .934, 95% CI:
-3.64–3.35) (Table 5).
Apart from this, the baseline scores of the corresponding
QoL measures were signiﬁcant predictors of linear trend of
QoL. All tests for ﬁrst-order interactions, and all tests on
the other predictors like gender, age, and disease severity
(appendix), were not statistically signiﬁcant (Table 5).
Generic health-related quality of life
The change scores of the EQ-5D VAS and the ﬁve separate
EQ-5D domains were not signiﬁcantly different for both
groups at one month after surgery (Table 4). HRQoL
increased similarly in both groups in the ﬁrst year after
surgery on EQ-5D VAS (P-Value = .593) and on all ﬁve
EQ-5D domains (Table 4).
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treatment had no statistically signiﬁcant effect on the linear
trend of the EQ-5D VAS (P-Value = .556, 95% CI: -2.81–
1.51; Table 5). The baseline scores of the EQ-5D VAS and
baseline anxiety score and gender were signiﬁcant predictors
of the linear trend of the EQ-5D VAS. All tests for ﬁrst-
order interactions, and all tests on the other predictors
(appendix), were not statistically signiﬁcant (Table 5).
Table 2 Comparison of demographic data, previous medical and cardiac history, and operative data between control (N = 207) and short-stay
intensive care (SSIC) patients (N = 201)
Study population
N
a Control N
a SSIC
Demographic data
Age (Years) Mean ± SD
b 206 62.0 ± 13.77 201 61.8 ± 10.67
Body mass index (Kg/M
2) Mean ± SD 193 27.4 ± 3.84 185 27.8 ± 3.55
Sex (male) n (%) 207 169 (81.6) 201 161 (80.1)
Civil state 201 198
Married n (%) 150 (72.5) 158 (78.6)
Unmarried no partner n (%) 40 (19.3) 31 (15.4)
Unmarried with partner n (%) 14 (6.8) 9 (4.5)
Education 195 196
Primary school not ﬁnished n (%) 2 (1.0) 5 (2.5)
Primary school n (%) 53 (25.6) 40 (19.9)
Lower education n (%) 47 (22.7) 57 (28.4)
Intermediate education n (%) 63 (30.4) 64 (31.8)
High education n (%) 30 (14.5) 30 (14.9)
Previous cardiac and medical history
Left ventricular ejection fraction n (%) 193 189
[35% 115 (55.6) 120 (59.7)
35–45% 30 (14.5) 27 (13.4)
40–50% 48 (23.2) 42 (20.9)
NYHA classiﬁcation angina
c n (%) 195 191
I 8 (3.9) 5 (2.5)
II 41 (19.8) 26 (12.9)
III 82 (39.6) 96 (47.8)
IV 64 (30.9) 64 (31.8)
Hypertension n (%) 204 88 (42.5) 201 86 (42.8)
Hypercholesterolemia n (%) 196 124 (59.9) 194 136 (67.7)
Smoking n (%) 199 69 (33.3) 198 73 (36.3)
Positive family anamneses n (%) 195 126 (60.9) 191 117 (58.2)
Diabetes mellitus n (%) 205 38 (18.4) 201 33 (16.4)
Operative data
Number of grafts Mean ± SD 204 3.2 ± 1.3 200 3.1 ± 1.2
Cardiopulmonary bypass time (in minutes) Mean ± SD 151 81.6 ± 35.3 153 77.4 ± 34.1
Aorta cross-clamp time (in minutes) Mean ± SD 151 52.5 ± 25.9 154 47.8 ± 27.3
Without aorta cross-clamping n (%) 56 (27.1) 47 (23.4)
Re-do CABG n (%) 207 14 (6.8) 201 10 (5.0)
Hospital stay
Intensive care stay Mean ± SD 207 29.9 ± 24.04 201 19.8 ± 27.30
Total hospital stay Mean ± SD 207 8.7 ± 5.10 201 8.0 ± 4.41
a N number of patients with data available on the reported variable
b SD Standard Deviation
c NYHA New York Heart Association
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The change score of the BDI and STAI-S did not differ in
both groups at 1 month after surgery (P-Value = .496,
95% CI: -0.13–0.65, P-Value = .259, 95% conﬁdence
intervals: -3.8 to -1.03) (Table 4).
The results of the repeated measures ANCOVA analysis
show no statistically signiﬁcant differences in the linear
trend at 1 year after surgery for both groups on BDI
(P-Value = .621) or STAI –S (P-Value = .653) (Table 4).
Discussion
Summary of study ﬁndings
This large, randomized controlled equivalence trial is to our
knowledgetheﬁrststudythatevaluatestheimpactofashort-
stay intensive care treatment (a type of fast-track treatment)
on disease-speciﬁc, generic, and domain-speciﬁc HRQoL in
the year after surgery in low-risk CABG patients.
After controlling for baseline differences and potential
confounding factors, like gender and age, the changes of dis-
ease-speciﬁc,generic,anddomain-speciﬁcHRQoLintheﬁrst
year after surgery appear to be similar for patients who
receivedtheshort-stayICtreatment(dischargewithin8 hafter
surgery) and for those who stayed overnight on the IC. The
scores on the domains’ physical and social functioning of the
MILQ were signiﬁcantly higher in the SSIC group compared
to the control group at 1 month after surgery. However, these
differences were no longer observed at one-year follow-up.
Fast-track treatments and HRQoL
The desirability of decreasing postcardiac surgery intensive
care utilization was recognized two decades ago [41], [40]
Table 3 Reasons of missing
data in baseline, 1-month and
1-year questionnaire in number
(percentages)
a same patient
Reason Control group N = 207 SSIC group N = 201
N % N %
Baseline questionnaire
Informative censoring
Psychological problems 1 0.3 0 0.0
Non-informative censoring
Lost questionnaire 0 0.0 1 0.3
Total 1 0.3 1 0.3
1-month questionnaire
Informative censoring
Deceased 1 0.5
a 0 0.0
Admitted to a hospital 1 0.5 0 0.0
Non-informative censoring
Not willing to ﬁll in 3 1.4 2 1.0
Private or family circumstances 1 0.5 0 0.0
No telephone number/address available 2 1.0 1 0.5
Reason censoring unclear
Admitted to a nursing home 2 1.0 0 0.0
Not reported 3 1.4 7 3.5
Total 13 6.3 10 5.0
1-year questionnaire
Informative censoring
Deceased 1 0.5
a 3 1.5
Non-informative censoring
Not willing to ﬁll in 2 1.0 4 2.0
Private or family circumstances 1 0.5 0 0.0
No telephone number/address available 3 1.4 3 1.5
Reason censoring unclear
Admitted to a nursing home 1 0.5 0 0.0
Not reported 18 8.7 11 5.5
Total 26 12.6 21 10.5
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123with cost containment as the main driving force [41].
Examples of these fast-track treatments that make IC dis-
charge within a few hours after surgery possible are the use
of fast-track anesthesia, normothermic temperature man-
agement, and early extubation at the intensive care. Due to
the heterogeneity of the interventions, differences in case-
mix, various questionnaires and variable points in time
used, a proper comparison between study ﬁndings difﬁcult.
Nevertheless, our results conﬁrm the ﬁnding of others [6,
12, 13] that fast-track treatments do not have an impact on
cognitive function. Royse et al. [15] found less posttrau-
matic stress and depression at 6-month postoperative in the
fast-track group receiving low-dose anesthetics compared
to the group which received a high dose. We did not ﬁnd
any evidence of a difference in the number of depressive
and anxious feelings in the two groups in the ﬁrst postop-
erative year. No comparison with other studies on the factor
of pain can be made as these trials only reported on pain in
the ﬁrst days after the IC treatment [5, 10–14, 16, 17].
Clinical relevance of study ﬁndings
A strong point of our study is its sample size. In the current
study, we were able to detect the possibility of a clinically
meaningful QoL difference at 1 year (of 0.4 points on the
MILQ,of0.3pointsontheEQ-5Ddomains,andof8pointson
theEQ-5DVAS)betweentheSSICandthecontrolgroup.As
none of these three scales at 1 year showed a statistically
signiﬁcant difference between both groups, the reported dif-
ferencesbetweenbothgroupscannotbedeﬁnedasaclinically
meaningful. This indicates that the short-stay intensive care
intervention does not have a relevant adverse impact on
HRQoL at 1 year after surgery. In another study, we investi-
gated the validity of both the MILQ and the EQ-5D. One of
the ﬁndings was that the baseline ceiling effects (a high
percentage of patients with a maximum score) in all EQ-5D
dimensions were substantial, but these were not found on the
MILQ-score and EQ-5D VAS. For the current study, this
indicatesthatthereisapossibilitythatnotallrelevantchanges
in HRQoL measured by means of the EQ-5D domains were
identiﬁed. However, as outcomes reported by means of the
EQ-5D domains are consistent with those ofthe EQ-5DVAS
and the MILQ, the impact of this on the study conclusions is
probably negligible.
The differences at 1-month postoperative on the physical
and social functioning of the MILQ were signiﬁcantly dif-
ferent between both groups, although this difference was no
longer observed at long-term follow-up. As the power calcu-
lationwasbasedon1 yeardifferencesinHRQoLbetweenthe
two groups, it is not possible to make a proper judgment
whether the reported small positive effects in the SSIC group
atshort term are ofclinicalrelevance.Ina previous paper,we
also reported generic HRQoL at 1 month after surgery as an
outcomemeasureintheeconomicevaluationoftheshort-stay
intensivecaretreatment.Thepatient’sanswerstotheﬁveEQ-
5D items were used to calculate the utility value, based on
population weights [24] (ranging from 0 to 1), and subse-
quently the D quality adjusted life months (D QALM’s) was
calculated. Thegeneric HRQoL signiﬁcantly improvedinthe
SSIC group when compared to the control group. In the cur-
rent study, this outcome was not reported because the aim of
thispaperwastoreportdatafromapatient’sviewpointandnot
fromaso-calledsocietalperspective.Theobserveddifference
measured at 1 month was very small (0.0238) and lower than
thescoreof0.03whichisconsideredclinicallyrelevanttothis
study [43], [42].
IfwecompareourﬁndingsoftheEQ-5Dchangescoresof
the EQ-5D at 12 months after surgery with those of results
reported by Badia et al. in patients receiving scheduled sur-
gery [22], the results of the domains of self-care, usual
activities, pain/discomfort, and EQ-VAS are very similar,
but the results of the other domains, such as mobility and
anxiety/depression, are different. The mean score on
mobility improved meaningfully clinical, whereas in our
study population no such an improvement was observed. In
contrast,patientsintheSSICstudyreportedadecreaseinthe
psychologicaldimensionoftheEQ-5D, whereasforpatients
scheduled for various types of surgery this score did not
Table 5 Results of linear regression analysis for prediction models
of HRQoL at 1 year after surgery
B 95% CI
a P Value
Model 1: Linear trend of MILQ-score
b
R-square = .334
Bo 2.43 2.14 to 2.72 \.001
Group .024 -.115 to .162 .736
MILQ-score at baseline -.435 -.50 to -.38 \.001
Model 2: Linear trend of Overall MILQ-Index
b
R-square = .208
Bo 77.29 \.001
Group -.148 -3.64 to 3.35 .934
Depression at baseline -.406 -.82 to .00 .050
Overall MILQ-Index at
baseline
-.368 -.45 to -.29 \.001
Model 3: Linear trend of EQ-5D VAS
c
R-square = .357
Bo 30.33 24.2 to 36.4 \.001
Group -.648 -.2.81 to 1.51 .556
Gender -5.00 -7.80 to -2.20 \.001
Anxiety at baseline .106 .01 to .20 .026
EQ-5D VAS at baseline -.424 -.48 to -.37 \.001
a CI Conﬁdence Interval
b MILQ Multidimensional Index of Life Quality
c VAS Visual Analogue Scale
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123change.Anexplanationforthesediscrepanciesbetweenboth
studies can be related to the differences in patient charac-
teristics. For instance, the mean age was lower in the study
performed by Badia et al. compared to the mean age in our
study. Furthermore, not only CABG patients but also liver
transplant and other types of cardio surgical interventions
wereincludedintheSpanishstudy.Anotherexplanationcan
be related to the differences in measuring the baseline QoL.
The retrospective rating of the baseline QoL in the Spanish
study can have resulted in an under- or overestimating of
these scores and hence, in an under- or overestimating of the
QoL change scores.
This study has the following limitations:
Ideally, preoperative administration of the HRQoL
questionnaires should be done before emotional
responses could confound the HRQoL measures, but
this was not possible due to logistic reasons. However, as
this study was comparative, this cannot have inﬂuenced
the study ﬁndings much. A measurement of pain within a
few days after treatment was not performed as it was
practically impossible.
The generalizability of this study may be somewhat
limited because the primary non-responders were older
patients, and women were overrepresented compared to
the responders. However, as all baseline characteristics
for the responders and the non-responders of both
treatment modalities were comparable, this cannot have
a large impact on our study results.
Another limitation of this study is that standard hypoth-
esis testing was used (the null hypothesis is equal means
in groups). The recommended approach of Jones et al.
(1996), where conclusions are drawn on the basis of an
appropriate conﬁdence interval using the prespeciﬁed
criteria of equivalence derived from the sample size
calculation, was not done. Finally, fatigue of the
responders may have biased the study ﬁndings. Other
limitations concerning the study design and patient
eligibility are described elsewhere [23].
Conclusions and recommendations
This randomized controlled equivalence trial evaluated the
impact of a short-stay intensive care protocol on HRQoL in
low-risk CABG patients. The short-stay intensive care treat-
mentappearstohavenoeffectondisease-speciﬁcandgeneric
HRQoLintheﬁrstyearaftersurgery.Asnoneoftheobserved
HRQoLdifferencesbetweenthetwogroupscanbedeﬁnedas
clinically meaningful, while the safety and ﬁnancial beneﬁts
oftheSSICinterventionalreadyhavebeendemonstrated[23],
froma patient’sperspective short-stayintensivecarecan also
beconsideredasagoodalternativepostoperativeICtreatment
in low-risk CABG patients.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix
See Table 6.
Table 6 Potential predictors of health-related quality of life used in the three regression models
Independent Source Coding Description
Group Case record form Care as usual = 0, SSIC = 1
Demographic data
Age (Years) Database Continuous High age [43–45]
Female sex Idem Female = 1, male = 0 Female [43, 45–49]
Civil state Self-reported With partner = 1, without partner = 0 No partner [48]
Education Idem Primary school not ﬁnished yes = 1, no = 0 Low education [26]
Previous cardiac and medical history
Left Ventricular ejection fraction
[50%
\50%
Database \50% = 1,[50% = 0[ 43, 50]
NYHA classiﬁcation angina
a
I–II
III–IV
Idem III–IV = 1, I–II = 0 NYHA classiﬁcation III–IV [43, 46]
Hypertension Idem Yes = 1, no = 0 History of Hypertension [45, 47, 49]
COPD
b Idem Yes = 1, no = 0 History of COPD [44, 45, 49]
CVA
c Idem Yes = 1, no = 0 History of CVA [45, 49, 52]
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